These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Nutritional neuropathies in tropical regions]. Collomb H; Giordano C Med Trop (Mars); 1967; 27(4):367-80. PubMed ID: 5621459 [No Abstract] [Full Text] [Related]
15. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Gherardi RK; Malapert D; Degos JD Muscle Nerve; 1993 Oct; 16(10):1129-30. PubMed ID: 8280259 [No Abstract] [Full Text] [Related]
16. [Neurologic manifestations of monoclonal gammapathies]. Uldry PA; Steck AJ; Regli F Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963 [TBL] [Abstract][Full Text] [Related]
17. The significance of significance: Overstating in the setting of many comparisons. Bromberg MB Clin Neurophysiol; 2014 May; 125(5):1073. PubMed ID: 24239454 [No Abstract] [Full Text] [Related]
18. Fine specificity of antibodies against phospholipids and beta-2-glycoprotein I in monoclonal gammopathy associated neuropathies. Matà S; Giudizi MG; Totaro M; Grippo A; Fedi S; Sorbi S J Neuroimmunol; 2007 Jan; 182(1-2):219-25. PubMed ID: 17161469 [TBL] [Abstract][Full Text] [Related]
19. Reply to "The significance of significance: overstating in the setting of many comparisons". Luigetti M; Padua L Clin Neurophysiol; 2014 May; 125(5):1073-4. PubMed ID: 24152743 [No Abstract] [Full Text] [Related]
20. Use of SEPs to localize degeneration in a rare polyneuropathy: studies on polyneuropathy associated with pigmentation, hypertrichosis, edema, and plasma cell dyscrasia. Shibasaki H; Ohnishi A; Kuroiwa Y Ann Neurol; 1982 Oct; 12(4):355-60. PubMed ID: 7149661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]